ArticleOncoimmunology2022

T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice.

Olmo Sonzogni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.